Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $13.2400 (-4.95%) ($13.1800 - $13.2400) on Fri. Apr. 29, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.05% (three month average) | RSI | 23 | Latest Price | $13.2400(-4.95%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2% a day on average for past five trading days. | Weekly Trend | EDIT declines -11.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(68%) IWO(62%) IWC(61%) IBUY(60%) IWM(59%) | Factors Impacting EDIT price | EDIT will decline at least -2.525% in a week (0% probabilities). VIXM(-29%) UUP(-15%) VXX(-10%) TBT(-8%) UNG(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.525% (StdDev 5.05%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-11.77(-188.9%) | Resistance Level | $16.61 | 5 Day Moving Average | $13.92(-4.89%) | 10 Day Moving Average | $14.5(-8.69%) | 20 Day Moving Average | $16.61(-20.29%) | To recent high | -37.9% | To recent low | 0% | Market Cap | $822m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |